Top Markets
#1 MowCat MowCat +48.90%
#2 Bermuda Shorts Bermuda Shorts +35.34%
#3 aPriori aPriori +23.54%
#4 Derive Derive +19.62%
#5 Velvet Velvet +19.35%
#6 Biconomy Biconomy +19.15%
#7 Audiera Audiera +17.60%
#8 Quack AI Quack AI +17.21%
#9 Perle Perle +15.57%
#10 Block Street Block Street +11.88%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Firebrick Pharma Limited Firebrick Pharma Limited

Firebrick Pharma Limited

FRE
Rangering i aksjer #35032
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered... Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Aksjekurs
$0.01904269
Sist synkronisert: 2026-08-14
Markedsverdi
$4.55M
Endring (1 dag)
0.00%
Endring (1 år)
-63.41%
Land
AU
Handel Firebrick Pharma Limited (FRE)

Kategori

Healthcare
EPS for Firebrick Pharma Limited (FRE)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Firebrick Pharma Limited er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Firebrick Pharma Limited fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -
US